my account
log out
|
|
my account
log out
|
Afuco™ Anti-Human CTSS ADCC Theraputic Antibody (Fsn0503h), ADCC Enhanced |
| Create: 08/09/2019 |
| Expired Date: | never |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | Anti-CTSS ADCC Enhanced Antibody (Fsn0503h) is an ADCC enhanced antibody produced by our Afuco™ platform. Fsn0503h is a fully human anti-Cathepsin S antibody with anti-tumour and anti-angiogenic properties. Cathepsin S is a cysteine protease highly expressed in many cancers including colorectal, breast, prostate and glioblastoma's. It is involved in tumour progression through extracellular matrix remodelling. Fusion Therapeutics has generated positive preclinical data demonstrating efficacy of Fsn0503h in multiple models both as a monotherapy and in combination with approved agents. https://www.creativebiolabs.net/Anti-CTSS-ADCC-Enhanced-Antibody-Fsn0503h-20492.htm |
 | |
| City: | Shirley[US]
 |
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 249 | |
| Feb 01 2023 | GVBE Buffer | 254 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 257 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 249 | |
| Aug 30 2019 |  | Anti-HSV-2 gH Antibody | 437 |
| Aug 30 2019 | | Anti-L. major LPG Antibody | 523 |
| Aug 30 2019 | | Anti-DENV-1 Antibody | 429 |
| Aug 30 2019 | | Anti-BPV-1 L1 Antibody | 446 |
| Aug 30 2019 | | Anti-H3N2 HA Antibody | 426 |
| Aug 30 2019 | | Anti-EIAV env Antibody | 457 |
| Copyright © toextrade Inc. All rights reserved. Contact us |